These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
701 related articles for article (PubMed ID: 36301977)
21. Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospital. Arankalle V; Kulkarni-Munje A; Kulkarni R; Palkar S; Patil R; Oswal J; Lalwani S; Mishra AC Front Immunol; 2022; 13():928501. PubMed ID: 36211366 [TBL] [Abstract][Full Text] [Related]
23. Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021. Ma C; Sun W; Tang T; Jia M; Liu Y; Wan Y; Han J; Rodewald L; Li J; Song Y; Wang Y; Wu D; Wang F; Zheng H; Tang L; Gao GF; Yin Z; An Z Vaccine; 2022 May; 40(20):2869-2874. PubMed ID: 35400561 [TBL] [Abstract][Full Text] [Related]
24. Adverse events and breakthrough infections associated with COVID-19 vaccination in the Indian population. Arora G; Taneja J; Bhardwaj P; Goyal S; Naidu K; Yadav SK; Saluja D; Jetly S J Med Virol; 2022 Jul; 94(7):3147-3154. PubMed ID: 35261064 [TBL] [Abstract][Full Text] [Related]
25. Antibody response after first and second-dose of ChAdOx1-nCOV (Covishield Singh AK; Phatak SR; Singh R; Bhattacharjee K; Singh NK; Gupta A; Sharma A Vaccine; 2021 Oct; 39(44):6492-6509. PubMed ID: 34600747 [TBL] [Abstract][Full Text] [Related]
26. Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data. Paris C; Perrin S; Hamonic S; Bourget B; Roué C; Brassard O; Tadié E; Gicquel V; Bénézit F; Thibault V; Garlantézec R; Tattevin P Clin Microbiol Infect; 2021 Nov; 27(11):1699.e5-1699.e8. PubMed ID: 34265462 [TBL] [Abstract][Full Text] [Related]
27. Severity and Outcome of Post-Vaccine COVID-19 among Healthcare Workers in a University Hospital in India. Vishnoi J; Sharma RK; Patel J; Sharma JC; Sharma KR; Mehta U J Med Life; 2023 May; 16(5):782-793. PubMed ID: 37520491 [TBL] [Abstract][Full Text] [Related]
28. Vaccination coverage and breakthrough infections of COVID-19 during the second wave among staff of selected medical institutions in India. Rahi M; Yadav CP; Ahmad SS; Nitika ; Das P; Sharma S; Baharia RK; Bhattacharya D; Deshmukh P; Dhatrak A; Dogra S; Eapen A; Goel P; Faizi N; Khan SA; Kochar SK; Kochar A; Kumar A; Mundra A; Narang R; Narain K; Pandey K; Pati S; Raghav P; Ranjha R; Shah S; Singh K; Singh PK; Singh RK; Kuttiatt VS; Soni R; Sreehari U; Malhotra S; Sharma A PLOS Glob Public Health; 2023; 3(4):e0000946. PubMed ID: 37027349 [TBL] [Abstract][Full Text] [Related]
29. Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study. Piernas C; Patone M; Astbury NM; Gao M; Sheikh A; Khunti K; Shankar-Hari M; Dixon S; Coupland C; Aveyard P; Hippisley-Cox J; Jebb SA Lancet Diabetes Endocrinol; 2022 Aug; 10(8):571-580. PubMed ID: 35780805 [TBL] [Abstract][Full Text] [Related]
30. Long-Term Safety Analysis of the ChAdOx1-nCoV-19 Corona Virus Vaccine: Results from a Prospective Observational Study in Priority Vaccinated Groups in North India. Kaur U; Fatima Z; Maheshwari K; Sahni V; Dehade A; Kl A; Yadav AK; Kansal S; Jaisawal V; Chakrabarti SS Drug Saf; 2023 Jun; 46(6):553-563. PubMed ID: 37133805 [TBL] [Abstract][Full Text] [Related]
31. Covid-19 Vaccines Available in India. Mukim M; Sharma P; Patweker M; Patweker F; Kukkar R; Patel R Comb Chem High Throughput Screen; 2022; 25(14):2391-2397. PubMed ID: 35293291 [TBL] [Abstract][Full Text] [Related]
33. Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study. Gram MA; Nielsen J; Schelde AB; Nielsen KF; Moustsen-Helms IR; Sørensen AKB; Valentiner-Branth P; Emborg HD PLoS Med; 2021 Dec; 18(12):e1003874. PubMed ID: 34919548 [TBL] [Abstract][Full Text] [Related]
34. Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines. Brunner-Ziegler S; Spath T; Kornek G; König F; Parschalk B; Schnetzinger M; Straßl RP; Savic R; Foit A; Resch H; Thalhammer F Clin Microbiol Infect; 2022 Apr; 28(4):596-601. PubMed ID: 34915073 [TBL] [Abstract][Full Text] [Related]
35. Covid-19 vaccination programme effectiveness against SARS-CoV-2 related infections, hospital admissions and deaths in the Apulia region of Italy: a one-year retrospective cohort study. Homan T; Mazzilli S; Chieti A; Musa A; Roth A; Fortunato F; Bisceglia L; Prato R; Lopalco PL; Martinelli D Sci Rep; 2022 Nov; 12(1):18597. PubMed ID: 36329239 [TBL] [Abstract][Full Text] [Related]
36. Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study. Md Yusof MY; Arnold J; Saleem B; Vandevelde C; Dass S; Savic S; Vital EM; Emery P Lancet Rheumatol; 2023 Feb; 5(2):e88-e98. PubMed ID: 36712951 [TBL] [Abstract][Full Text] [Related]
37. Assessing COVID-19 Vaccine Uptake and Effectiveness Through the North West London Vaccination Program: Retrospective Cohort Study. Glampson B; Brittain J; Kaura A; Mulla A; Mercuri L; Brett SJ; Aylin P; Sandall T; Goodman I; Redhead J; Saravanakumar K; Mayer EK JMIR Public Health Surveill; 2021 Sep; 7(9):e30010. PubMed ID: 34265740 [TBL] [Abstract][Full Text] [Related]
38. Effectiveness of COVID-19 vaccine in preventing infection and disease severity: a case-control study from an Eastern State of India. Singh C; Naik BN; Pandey S; Biswas B; Pati BK; Verma M; Singh PK Epidemiol Infect; 2021 Oct; 149():e224. PubMed ID: 34632972 [TBL] [Abstract][Full Text] [Related]
39. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021. León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222 [TBL] [Abstract][Full Text] [Related]
40. First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India. Tsundue T; Namdon T; Tsewang T; Topgyal S; Dolma T; Lhadon D; Choetso T; Woesal T; Yangkyi T; Gupta A; Peters D; Paster Z; Phunkyi D; Sadutshang TD; Chaisson RE; Dorjee K BMJ Glob Health; 2022 May; 7(5):. PubMed ID: 35609920 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]